Clinical Trials
2 trialsNCT04756505 2023-12-27
Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT01417546 2021-10-18
NHS-IL12 for Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed